0001179110-20-009004.txt : 20200813
0001179110-20-009004.hdr.sgml : 20200813
20200813174719
ACCESSION NUMBER: 0001179110-20-009004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200812
FILED AS OF DATE: 20200813
DATE AS OF CHANGE: 20200813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHEELER CRAIG A
CENTRAL INDEX KEY: 0001229450
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 201100481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-08-12
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001229450
WHEELER CRAIG A
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Common Stock
2020-08-12
4
M
0
6171
A
18090
D
Common Stock
2020-08-13
4
S
0
2777
28.55
D
15313
D
Common Stock
36725
I
Craig A Wheeler 2016 Annuity Trust
Common Stock
48263
I
Craig A Wheeler 2018 Annuity Trust
Common Stock
573022
I
Craig Wheeler Revocable Trust
Restricted Stock Units
2020-08-12
4
M
0
6171
0
D
Common Stock
6171
37032
D
Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018.
Restricted Stock Units convert into common stock on a one-for-one basis.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.
This transaction was executed in multiple trades at prices ranging from $28.18 to $29.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
/s/ R. Mark Chamberlin as attorney in fact
2020-08-13